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Abstract
This longitudinal study used a representative community sample of same-sex twins (485 monozygotic pairs, 271 dizygotic pairs) to study longitudinal changes
in genetic and environmental influences on nicotine dependence (NicD) symptoms and major depressive disorder (MDD) symptoms and the longitudinal
relationships between NicD and MDD symptoms at three relatively discrete ages spanning middle adolescence to early adulthood (ages 15, 18, and 21).
Clinical interviews were used to assess NicD and MDD symptoms lifetime at age 15 and during the previous 3 years at the two subsequent assessments.
Biometric models revealed similar patterns of findings for NicD and MDD. Heritability increased with age, particularly between ages 15 and 18. Shared
environmental influences were small, and the proportion of variance attributed to shared environmental influences decreased with age. Nonshared
environmental influences were moderate to large in magnitude and were entirely age specific. Both NicD and MDD symptoms showed considerable stability
from age 15 to 21, and at each age those with one disorder showed elevated rates of the other. However, a cross-lagged model revealed no longitudinal
predictive relationships between MDD symptoms and NicD symptoms after accounting for stability of symptoms within disorders. In summary, the transition
between middle and late adolescence is a critical period for developmental shifts in the magnitudes of genetic and environmental influences on both
MDD and NicD symptoms. Despite similarities in the development of genetic and environmental influences for the two phenotypes, the association between
NicD and MDD reflects concurrent covariation rather than one phenotype being an antecedent influence on the subsequent development of the other.

Adolescence and early adulthood are developmental periods
characterized by many transitions as youths become more independent, spend less time with parents and more time with
peers, and engage in a variety of risk behaviors (e.g., drugs,
sexual relationships). This is also a period of risk and peak
incidence for many psychiatric disorders, such as major depressive disorder (MDD) and nicotine dependence (NicD;
Chassin, Presson, Rose, & Sherman, 1996; Costello, Mustillo,
Erkanli, Keeler, & Angold, 2003; Lewinsohn, Rohde, & Seeley, 1998), two disorders with major public health consequences. Depression is the leading cause of disability worldwide (Ustun & Kessler, 2002), and because it exacerbates the
course and outcome of many health problems, its morbidity
is comparable to the most serious medical disorders (Cassano
& Fava, 2002; Greden, 2001). Nicotine use is the leading avoidable cause of morbidity and premature mortality worldwide
(Mathers et al., 2000; US Department of Health and Human
Services, 1994). Moreover, these health risks and societal bur-

dens are increased when depression and nicotine use co-occur
(Grant, Hasin, Chou, Stinson, & Dawson, 2004; Lopez, 2006).
Given that these disorders typically begin to emerge during
adolescence and tend to be chronic, reducing the significant
health and economic burdens associated with these disorders
requires intervening and minimizing early risks to thwart the
cascade of events leading to impairing psychopathology.
A cascade of genetic influences and environmental exposures unfolds over time, creating variability in how successfully youths adapt to the changing demands of this developmental period and escape or succumb to risks for MDD and
NicD. The emergence of symptoms during middle adolescence may be triggered by cumulative environmental risks
that have reached a threshold, the introduction age-specific
environmental influences (e.g., more time spent with deviant
and victimizing peers), and/or genetic influences that come
about during this period. The purpose of the present study
was to investigate developmental changes in genetic and environmental influences on NicD symptoms and MDD symptoms
at three discrete ages across the high-risk period spanning middle adolescence, when symptoms of these disorders begin to
emerge for many at-risk youths, to early adulthood, when rates
and severity of these disorders have reached adult, impairing
levels. In light of the added burden associated with the co-occurrence of these disorders, the present study also investigates
the extent to which these disorders influence one another during
this period.

This study was supported in part by National Institutes of Health Grants DA05147, AA-09367, and 017069. We thank the participating families who
generously gave their time to the study and the many staff members and
research assistants who contributed to the overall conduct of the study.
Address correspondence and reprint requests to: Erin Tully, Department
of Psychology, Georgia State University, P.O. Box 5010, Atlanta, GA 303025010; E-mail: etully2@gsu.edu.
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Cascades of Interacting Genetic and Environmental
Effects Shape the Development of Psychopathology
Psychopathology develops through various dynamic processes
that unfold throughout development (Cicchetti, 1984; Sroufe &
Rutter, 1984) and involve genes, the environment, and their interplay (Rutter, Moffitt, & Caspi, 2006). Genetic and environmental influences underlie personal characteristics (e.g., maladaptive coping skills, negative affect) and experiences (e.g.,
stressful events, parental psychopathology) that create individual patterns of adaptation to salient developmental challenges
and thus create variability in psychopathology (Sroufe & Rutter, 1984). For example, genotype–environment interactions
(i.e., individuals with different genotypes responding differently to the same environment) contribute to resilience among
some individuals exposed to stressful situations and the development of psychopathology among others exposed to the same
stressors.
At the same time, experiences shared among individuals at
given developmental periods (i.e., autonomy from parents)
likely result in general trends for genetic and environmental
mechanisms to have greater or lesser influences at various
points during development. For instance, genotype–environment correlations, or tendencies for individuals to experience
environments that are correlated with their genotype, may result in increased genetic influences with age. Genotype–environment correlations occur for three main reasons: (a) parents
provide both genes and early environments to their children,
that is, passive genetic–environment correlations; (b) individuals actively seek environments that reinforce their genetically influenced dispositions, that is, active genetic–environment correlations; and (c) genetically influenced behaviors
tend to elicit certain environmental responses, that is, evocative/reactive genetic–environment correlation (Plomin, DeFries, & Loehlin, 1977; Scarr & McCartney, 1983). Passive
gene–environment correlations have their greatest influence
when children are young and parents exert considerable influence on their environments. Active gene–environment correlations become more important during adolescence and early
adulthood as individuals gain more independence and thus
are freer to seek out their environments. Heritability estimates
will increase with age with the growth of active genotype–
environment correlations (i.e., niche-fitting as autonomy increases during adolescence) and the decline of passive genetic–environment correlations on a given trait. This idea
is supported by a review and meta-analysis that found agerelated increases in heritability estimates for various behavioral and psychiatric phenotypes (Bergen, Gardner, & Kendler, 2007). Undoubtedly, the processes through which genes
and the environment influence psychopathology are complicated. Age-specific genetic and environmental effects
may exert their influences at discrete points during development, cumulative effects of various genetic and environmental factors may alter the relative importance of these
factors across development, or both cumulative and age-specific effects may interact in ways that result in fluctuations in

E. C. Tully, W. G. Iacono, and M. McGue

the enhancement and overshadowing of these factors across
development.
The progressive and bidirectional influences of genes and
environmental factors on psychopathology can be exemplified by research on smoking behavior. Adolescents of parents
who smoke are more likely to smoke cigarettes and develop
NicD (Clark, Kirisci, & Moss, 1998; Kandela, Hua, Grieslerb,
& Schaffranc, 2007; Kardia, Pomerleau, Rozek, & Marks,
2003; Lieb, Schreier, Pfister, & Wittchen, 2003; Vogel, Hurford, Smith, & Cole, 2003). The transmission of risk is partially attributable to genes that contribute to smoking initiation
and persistence in adolescents (Li, Cheng, Ma, & Swan, 2003;
Keyes, Legrand, Iacono, & McGue, 2008). At the same time,
low parental monitoring and parental approval of smoking increase the likelihood of adolescents smoking tobacco (Biglan,
Duncan, Ary, & Smolkowski, 1995), largely because deficits
in parental monitoring lead to affiliation with deviant peers
(Patterson, 1982), which in turn increase the likelihood of tobacco use, abuse of other substances, deviant behavior, and a
myriad of other problems (Biglan et al., 1995; Hu et al., 2006;
Kandela et al., 2007; McGue, lacono, & Krueger, 2006). These
parenting risk mechanisms are not solely environmentally
mediated because both peer groups (Baker & Daniels, 1990;
Manke, McGuire, Reiss, Hetherington, & Plomin, 1995; Pike,
McGuire, Hetherington, Reiss, & Plomin, 1996) and the characteristics of parent–child relationships (Elkins, McGue, & Iacono, 1997; Plomin, Reiss, Hetherington, & Howe, 1994) are
genetically influenced. Research suggests that the association
between peer affiliation and smoking initiation is genetically influenced (White, Hopper, Wearing, & Hill, 2003) and the associations among peer deviance, parent–child relationship problems, and early substance use is mediated by environmental
influences shared among members of the same family (Walden,
McGue, Iacono, Burt, & Elkins, 2004). In other words, mutual
interacting genetic and environmental influences over the course
of development lead to acascade of lasting and interacting effects
on adolescents’ relationships and social environment, NicD, and
comorbid psychopathology.
Genetic and Environmental Influences
on Depression and NicD
Twin studies provide a method for estimating genetic and
environmental influences on MDD and NicD symptoms by
comparing similarity in symptoms between monozygotic
(MZ) twins, who share 100% of their genes, to similarity in
symptoms between dizygotic (DZ) twins, who share on average 50% of their genes. Biometric modeling of data from twin
studies provides estimates of additive genetic effects, shared
environmental effects (i.e., environmental effects shared by
reared-together relatives that are sources of behavioral similarity), and nonshared environmental effects (i.e., environmental effects that differ for reared-together relatives and
are sources of behavioral dissimilarity). Thus, twin studies
can be used to separate variability in MDD and NicD into
the proportions of variability attributed to genetic influences
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(i.e., heritability), shared environmental influences, and nonshared environmental influences.
Various measures of tobacco use (e.g., smoking initiation,
regular/daily smoking, NicD) have been found to be highly heritable in adults (Carmelli, Swan, Robinette, & Fabsitz, 1990;
Heath, Madden, & Martin,1998; Kaprio et al., 1982; Kendler
et al., 1999) and adolescents (Maes et al., 1999; McGue, Elkins,
& Iacono, 2000; Slomkowski, Rende, Lloyd-Richardson, &
Niaura, 2005). Meta-analytic reviews of the heritability of tobacco use report that 37–60% of the variance in smoking initiation and 46–59% of the variance smoking persistence can be
accounted for by genetic factors (Hall, Madden, & Lynskey,
2002; Li et al., 2003; Sullivan & Kendler, 1999), with smaller
heritabilities more common in samples with younger mean
ages. The shared environment also appears to play an important
role in smoking during adolescence (Boomsma, Koopmans,
van Doornen, & Orlebeke, 1994), although estimates of shared
environmental effects vary considerably across studies. Some
studies find that shared environmental influences account for
more variation than genetic influences (Koopmans, Slutske,
Heath, Neale, & Boomsma, 1999), whereas other studies find
no significant shared environmental influences (Maes et al.,
1999).
Inconsistencies in estimates of these influences are likely
a function of different ages and age ranges of samples as well
as the diverse measures of smoking and tobacco use. Shared
environmental influences are often stronger for smoking initiation, which typically occurs during early adolescence,
than for daily and persistent smoking and NicD (Stallings,
Hewitt, Beresford, Heath, & Eaves, 1999; Sullivan & Kendler, 1999), which develop later. Although these findings suggest the possibility of developmental changes in genetic and
environmental influences on tobacco use, almost no published studies have tested longitudinal models for changes
in these measures across adolescent development. A metaanalysis of age-related changes in the heritability of smoking
initiation (and other behavioral phenotypes) across adolescence and early adulthood reported a very small and nonsignificant overall effect size for an increase in heritability (Bergen
et al., 2007). However, the small effect size reflected considerable variability in estimates across studies with the only two
longitudinal studies supporting slight increases in genetic
influences (Slomkowski et al., 2005; White et al., 2003). Finally, gender is another potential source of variation in the
estimates, with some evidence supporting gender differences
in the proportions of genetic and environmental influences
(Kendler, Thornton, & Pedersen, 2000; Li et al., 2003; McGue
et al., 2000), but gender differences are typically small and
nonsignificant and support both larger (White et al., 2003)
and smaller (Boomsma et al., 1994) shared environmental
estimates for male compared to female adolescents.
The literature on genetic and environmental influences on
depression in youths is also limited by few longitudinal studies, differences in methodology, and inconsistent findings.
A review and meta-analysis on the genetic epidemiology of
depression in adults reported that variability in depression
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is approximately 40% due to additive genetic factors and
60% due to nonshared environmental factors with no evidence of shared environmental influences (Sullivan, Neale, &
Kendler, 2000). Twin studies typically find that depression in
adolescents is also heritable (Eaves et al., 1997; Eley & Plomin,
1997; Eley & Stevenson, 1999; Hewitt, Silberg, Neale, Eaves,
& Erickson, 1992; Rende, Plomin, Reiss, & Hetherington,
1993; Schmitz, Fulker, & Mrazek, 1995), but the proportions
of variance in depression attributed to genetic and environmental influences are highly inconsistent across studies and
likely depend on several factors, such as age and sex compositions of the samples and measurement instrument. Comparisons of heritability estimates across studies with samples of
varying mean ages suggest that developmental changes in the
magnitude and proportion of genetic and environmental influences are likely. The studies generally find significant shared
environmental influences on depressive and internalizing symptoms in child samples but not in adolescent samples (Rice,
Harold, & Thaper, 2002a; Schmitz et al., 1995; Thapar & McGuffin, 1994), and genetic influences have been found to account
for larger proportions of variance in adolescents’ depression
symptoms than children’s depression symptoms (Rice, Harold, & Thaper, 2002b; Scourfield et al., 2003). A few studies
of children and adolescents found age-related declines in heritability estimates of depression symptoms (O’Connor, McGuire,
Reiss, Hetherington, & Plomin, 1998; O’Connor, Neiderhiser,
Reiss, Hetherington, & Plomin, 1998) and internalizing symptoms (Gjone, Stevenson, Sundet, & Eilertsen, 1996).
Most of these twin studies use paper and pencil measures
of current (e.g., during the previous 2 weeks or 3 months) depression symptoms (e.g., Center for Epidemiologic Studies
Depression Scale, Radloff, 1977; Child Depression Inventory, Kovacs, 1985) or current (i.e., during the previous 6
months) internalizing symptoms (e.g., Child Behavior Checklist, Achenbach, 1991). Only a few studies have used clinical
or diagnostic interviews to obtain measures of MDD symptoms and diagnoses over longer periods of time and, given
that self-report instruments have been found to overestimate
rates of depression compared to clinical interviews of depression (Schepis & Rao, 2005), estimates may depend on the
measurement instrument used. Glowinski, Madden, Bucholz,
Lynskey, and Heath (2003) studied female youths aged 12–
23 and found that, similar to findings in adults, the variance
in lifetime diagnoses of MDD was accounted for by genetic
influences (40%) and nonshared environmental influences
(60%), but shared environmental influences did not account
for a significant portion of the variance (Glowinski et al.,
2003). Ehringer, Rhee, Young, Corley, and Hewitt (2006)
used diagnostic interviews to measure MDD symptoms in
male and female adolescents aged 12 to 19 years. Contrary
to the Glowinski et al. (2003) study, they found significant
shared and nonshared environmental influences but nonsignificant genetic influences (10–16%) on both past year and lifetime MDD diagnoses (Ehringer et al., 2006). The larger genetic influences in the Glowinski et al. (2003) study may be
explained by the use of an exclusively female sample with
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an age range that included young adults and use of diagnoses
rather than symptom counts.
In summary, existing research suggests the possibility of
age-related changes in the genetic epidemiology of depression
and NicD, but integration of findings across studies to answer
developmental questions is limited by few longitudinal studies
and diversity of measurement instruments. Most notably, the
majority of these studies estimated genetic and environmental
influences in samples of youths with wide age ranges that
span multiple developmental levels, thus potentially masking
important developmental changes in these influences, and
most studies did not use diagnostic interviews to assess clinically relevant symptoms of MDD or NicD. In the current
study, longitudinal twin data were used to answer developmental questions about changes in the nature of genetic and
environmental influences on MDD and NicD assessed
through clinical interviews at three developmentally important, discrete ages. More specifically, the longitudinal data
allow us to quantify developmental changes in the magnitude
of genetic and environmental influences on MDD and NicD
symptoms, identify developmental periods when genetic influences on these phenotypes become more predominant,
and examine the extent to which the same genetic and environmental factors influence the phenotypes across different ages
or have developmental specificity and influence the phenotypes during a particular developmental period only.
Comorbidity and Longitudinal Relationship
Between MDD and NicD in Youths
Adolescence and early adulthood are key periods not only for
the emergence of NicD and MDD but also for the onset of
depression and smoking co-occurrence. Tobacco use and
depressed mood tend to co-occur concurrently and when lifetime measurements are used in samples of adolescents and
young adults, although the magnitudes of the associations
vary across studies (Fergusson, Lynskey, & Horwood, 1996;
Hu et al., 2006; Pedersen & von Soest, 2009). Studies of longitudinal associations between depression and nicotine use in
adolescents also revealed mixed findings regarding both the
size and the direction of the associations, with some studies
suggesting that depressed mood predicts later NicD (Griesler
et al., 2008; Patton, Coffey, Carlin, Sawyer, & Wakefield,
2006), other studies suggesting that smoking initiation predicts later depressive episodes (Brown, Lewinsohn, Seeley, &
Wagner, 1996), and a meta-analysis concluding that the associations are bidirectional (Chaiton, Cohen, O’Loughlin, &
Rehm, 2009). Differences in methodology, such as variability
in time intervals between assessments, differences in ages and
age ranges of participants, inclusion of various covariates in
the analyses, and wide variability in instruments used to assess
depression and tobacco use, likely contributed to the discrepant
findings.
Another significant limitation of the existing research is
the failure of most studies to adequately account for the effect
of stability of depression and tobacco use on longitudinal
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relationships between these variables, for example, by using
cross-lag analyses. Previous depressive episodes predict future
depressive episodes (Fombonne, Wostear, Cooper, Harrington, & Rutter, 2001; Harrington, Fudge, Rutter, Pickles, &
Hill, 1990; Rao, Hammen, & Daley, 1999) and early tobacco
use predicts later tobacco use and NicD (Eissenberg & Balster,
2000; Riley et al., 1996; Russell, 1990). Thus, analyses used to
quantify the temporal relationships between these two constructs should account for history of depression and tobacco
use. Wang, Fitzhugh, Turner, Fu, and Westerfield (1996) ran
a cross-lagged analysis on a four-item self-report of depressive
symptoms and self-reported frequency of smoking and found
evidence supporting reciprocal associations between these
constructs over approximately a 4-year period in a sample of
adolescents and young adults. This study had significant limitations, including a 6-year age range of participants and measures that assessed depression and smoking during only a portion of the time elapsing between measurements (last year for
depression, last 30 days for smoking).
In summary, research supports continuity within disorders
across time and concurrent associations across disorders, but
questions remain about the extent to which one disorder influences the other disorder in an enduring way. Both genetic and
nonshared environmental factors have been found to account
for associations between various measures of nicotine use (e.g.,
daily smoking, NicD) and depression (e.g., MDD diagnoses,
self-reported current symptoms) in adults (Kendler et al.,
1993; Lyons et al., 2008; McCaffery, Niaura, Swan, & Carmelli, 2003). However, little is known about these associations during the formative years of adolescence and early
adulthood when use of cigarettes and MDD emerge and approach adult levels. To the extent that there are developmental
changes in genetic and environmental influences on MDD
and NicD, associations between NicD and MDD may also
vary with age. In this study, we used a cross-lagged panel
model to study the effects of NicD symptoms on subsequent
levels of MDD symptoms and MDD symptoms on the subsequent levels of NicD symptoms while accounting for the
stability of both disorders at multiple time points. In addition,
clinical interviews were used to assess symptoms of MDD and
NicD.
Hypotheses
Longitudinal twin and cross-lagged models were used to address 10 hypotheses about developmental changes in genetic
and environmental influences on MDD and NicD symptoms
and longitudinal associations between MDD and NicD symptoms. The twins were studied at three discrete ages (15, 18,
and 21 years) within narrow age ranges. The ages correspond
to three important developmental periods: (a) middle adolescence, when depressed mood and smoking initiation and experimentation are beginning to rise; (b) late adolescence, when
symptoms become more impairing and clinically significant;
and (c) early adulthood, when point prevalence rates of both
disorders have reached their peaks. These developmental peri-
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ods are marked by great change in the lives of youths as they
spend more time away from their parents and eventually leave
their families and learn to function independently (Roisman,
Masten, Coatsworth, & Tellegen, 2004), making them critical
ages for changes in genetic and environmental influences as
well. The clinical interviews used to assess symptoms of
MDD and NicD provided the opportunity for guided, standardized assessments during the entire period between time points
and for obtaining valid measures of both disorders.
First, given that the strongest predictor of each disorder is
a history of the disorder, we hypothesized that NicD symptoms and MDD symptoms would be relatively stable (i.e.,
correlated within disorders) across assessments. Second, we
predicted that the universal and consequential growth in independence and niche fitting in adolescence and early adulthood would result in age-related increases in the heritability
of both NicD and MDD. Third, given the stability of both
NicD and MDD, we predicted that some of the same genetic
factors would contribute to these phenotypes across the three
discrete ages. Nevertheless, we expected that new genetic influences would emerge at older ages as exposure to environmental and genetic cues change with age. Fourth, shared
environmental influences were expected to decrease with
age and become trivial in early adulthood, but to the extent
there were small shared environmental influences at older
ages we expected they would be shared with earlier ages.
Fifth, we predicted that new environmental influences shared
among members of the same family would not emerge and
have influence in early adulthood. Sixth, we expected nonshared environmental influences on both MDD and NicD
symptoms to increase with age as twins become more independent from their parents and each other and risk exposures
unique to each twin (e.g., separate groups of friends, distinct
stressful events) accumulate and become more influential
over time. Seventh, we predicted that these unique environmental risk factors would largely differ depending on developmental level and thus the nonshared environmental factors
would contribute little to stability in MDD and NicD across
the three ages.
Eighth, given findings of co-occurrence of depression
and nicotine use in samples of adolescents and young adults,
we predicted that symptom counts for the two disorders
would be correlated concurrently at all three ages. Ninth,
we hypothesized that symptoms of one disorder would be
correlated with symptoms of the other disorder across assessments, although the discrepant effect sizes in existing research provided no indication about the expected size of the
associations. Tenth, we evaluated the degree to which the occurrence of NicD symptoms at an early age influenced the
subsequent development of MDD and early MDD symptoms
influenced subsequent NicD symptoms after accounting for
the stability of each disorder over time. We made no specific
predictions about the size or direction of these associations
given the limitations of existing research on longitudinal associations between depression and nicotine use, especially
because there are few studies of clinical phenotypes in adoles-
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cents and young adults and almost no studies that account for
stability of the disorders across time.
Method
Sample
The sample consisted of 756 same-sex twin pairs (50.3% female, 64% MZ) from the Minnesota Twin Family Study
(MTFS), which is a large epidemiological and longitudinal
study of twins who were identified from birth records using a
population-based method. The participation rate was 82.7%
for participants who met inclusion criteria (i.e., lived within
than a 1-day drive to Minneapolis, were not adopted by nonrelatives, and were free from mental or physical handicap that precluded their participation). The MTFS sample was demographically reflective of the population of the state of Minnesota at
the time of the twins’ births: approximately 98% Caucasian;
mean occupational status (Hollingshead) for both fathers and
mothers corresponding to clerical, sales, and technician (3.9
and 3.7, respectively); and minimal differences on indicators
of socioeconomic status between families who participated
and families who did not participate (Iacono, Carlson, Taylor,
Elkins, & McGue, 1999). All participants provided written informed consent or assent as appropriate. Additional information about recruitment and the sample can be found elsewhere
(Iacono et al., 1999; Iacono, McGue, & Krueger, 2006).
Participants were assessed at uniform, discrete ages. Participants were first assessed when the twins were 11 years old
(M ¼ 11.72, SD ¼ 0.43), and they returned for three followup assessments approximately every 3 years. Given extremely
low lifetime rates of NicD diagnoses (0.2%) and MDD diagnoses (0.7%) and small symptom counts for NicD (M ¼ 0.01,
SD ¼ 0.20) and MDD (M ¼ 0.10, SD ¼ 0.64) at age 11, this
paper includes data from only the three follow-up assessments
at mean ages of 14.80 (0.51), 18.16 (0.65), and 21.46 (0.77)
years. We refer to the three assessments by the rounded mean
age of the participants at each assessment: 15 (middle adolescence), 18 (late adolescence), and 21 years (early adulthood).
Measures
At each time point, structured interviews were administered to
the twins by trained interviewers to assess DSM-III-R (the
DSM in use at the commencement of the study) symptoms
of NicD and MDD. The Substance Abuse Module (Robins,
Baber, & Cottler, 1987), a supplement to the Composite International Diagnostic Interview (Robins et al., 1988), was
used to assess NicD diagnoses and symptom counts; the Diagnostic Interview for Children and Adolescents, Revised
(Reich & Welner, 1988) was used to assess MDD diagnoses
and symptoms at age 15; and the Structured Clinical Interview for DSM-III-R (Spitzer, Williams, & Gibbon, 1987)
was used to assess MDD diagnoses and symptoms at ages
18 and 21. According to DSM-III-R criteria for MDD, individuals with symptom counts greater than zero experienced
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depressed mood or anhedonia for a period of at least 2 weeks.
Reliability for diagnoses of MDD and NicD, established on a
subset of 600 participants, was good (Cohen a  0.82 for both
disorders). Diagnoses and symptom counts at 15 years were
assessed lifetime until age 15, and diagnoses and symptom
counts at ages 18 and 21 years were assessed since the previous assessment (3 years). Symptom counts rather than
the presence or absence of a diagnosis were selected for the
main analysis because symptom counts are more sensitive
to the progression of disorder development during this period
when symptoms of these disorders are just beginning to
emerge. Symptom counts were regressed on age and the resulting residuals were log transformed and used in the twin
analyses.
Zygosity was determined on the basis of agreement among
three separate estimates: (a) a standard parent-report zygosity
questionnaire, (b) subjective evaluations of twins’ physical
similarity by experienced MTFS staff members, and (c) anthropometric measures (ponderal index, cephalic index, and
fingerprint ridge count). When determination of zygosity
was inconsistent across the three measures, serological analyses were performed. Accuracy of this method was evaluated
in a subsample of 50 twin pairs for which agreement among
the three measures was always confirmed by the serological
analysis.
Statistical analyses
Biometric model fitting. The size of genetic and environmental effects at each age, the magnitude of age differences
in these effects, and the degree of age overlap versus specificity in the effects were examined using three-factor Cholesky

decomposition models. Cholesky decomposition is a multivariate technique based on the principles of factor analysis
that was used to estimate genetic and environmental contributions to variance in symptoms at each age and covariance between symptoms across time. This model provided estimates
of additive genetic effects (A), shared environmental effects
(C, environmental effects that are shared by reared-together
relatives and are sources of behavioral similarity), and nonshared environmental effects (E, environmental effects that
differ for reared-together relatives and are a source of behavioral dissimilarity). One Cholesky model was calculated for
MDD symptoms, and a separate model was calculated for
NicD symptoms.
Figure 1 includes the three-factor ACE Cholesky model
used in this study. Genetic and environmental contributions
to variance in age 15 phenotypes are obtained by squaring
the respective path coefficients (a11 , c11 , e11 ). Variance in
the phenotypes at age 18 is divided into components attributable to genetic and environmental influences present at age
15 (a21 , c21 , e21 ) and residual (new) components that are independent of the genetic and environmental variance at age
15 (a22 , c22 , e22 ). Variance in the phenotypes at age 21 is divided into components attributable to genetic and environmental influences present at age 15 (a31 , c31 , e31 ) and present
at age 18 but not 15 (a32 , c32 , e32 ) and residual (new) components that are independent of the genetic and environmental
influences present at age 15 and 18 (a33 , c33 , e33 ). To analyze
changes in genetic and environmental influences across the
ages, fit statistics for a series of Cholesky models in which
the A, C, and/or E estimates were constrained to be equal
across age were compared to fit statistics for models in which
the estimates were free to vary.

Figure 1. The three-factor Cholesky decomposition model used in this study. The model decomposes the variance in liability to nicotine dependence symptoms (NicD Sx) or major depressive disorder symptoms (MDD Sx) into components attributable to additive genetic effects (Ai ), nonshared environmental effects (Ei ), and shared environmental effects (Ci ; not depicted for ease of presentation) at each of the three assessments (i ¼ 1,
2, 3). The individual paths (represented by lowercase letters followed by numerals) can be squared to estimate the proportion of variance accounted
for by the genetic and environmental influences. This figure represents only one twin, and the identical model is also calculated for the co-twin.
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Both biometric models were fit to variance–covariance
matrices in the Mx statistical software system (Neale, Boker,
Xie, & Maes, 1999). Variance–covariance matrices were calculated using an expectation–maximization algorithm, which
uses an iterative procedure to compute maximum-likelihood
estimates, thus allowing the use of all relevant twin data regardless of the number of assessments completed. In this procedure, missing data are assumed to be missing at random
after accounting for the relationship with available data at other
assessments. For both models, separate variance–covariance
matrices were calculated for males and females to account
for gender differences in mean levels, variance, and covariance
of symptoms. Then, parameters were constrained to be equal
across sexes.
The models were fit using the maximum-likelihood option
in Mx, with parameters estimated to minimize two times the natural logarithm of the multivariate normal likelihood (22LL).
Differences in the minimized value of 22LL between the
baseline and more restrictive models yield a likelihood x2
test that is used to test the significance of the model with constraints. A nonsignificant x2 difference test indicates that the
more restrictive model provides an appropriate fit to the data,
and in general, this more parsimonious model is preferred.
The Akaike information criterion (AIC ¼ x2 2 2Ddf) is also
reported. It is an alternative to the x2 goodness of fit test statistic that is less likely to result in rejection of the more restrictive model when deviations between the baseline and restricted
model are relatively small but sample sizes are large. Models
that minimize AIC are preferred.
Cross-lagged model fitting. Cross-lagged panel models were
run to analyze the relationship between NicD symptoms and
MDD symptoms over time at ages 15, 18, and 21. In these
models, symptoms are a function of (a) symptoms of both disorders at the previous point in time and (b) innovations, which
are new sources of influence that account for variance not

837

accounted for by the effects of either disorder at the previous
time point. The innovations are disorder specific, and correlations across disorders within time points were included in the
models. Latent variable models were fit to the raw symptom
count data using structural equation modeling software (Mplus
5.2; Muthén & Muthén, 1998–2007). Maximum likelihood estimation with robust standard errors was used, allowing for the
use of all available data regardless of missing data at particular
time points. The nonindependent nature of the twin data was
accounted for by nesting individuals within twin pairs using
the survey sampling method for estimating standard errors in
clustered data. To account for sex differences in symptom
counts, a two-group model was used first to estimate parameters separately for males and females and second to constrain
all paths to be equal across the sex cohorts. Means were not
constrained to be equal across sexes though, which allowed
for gender differences in mean symptom counts at each age.
A model constraining all cross-paths between NicD symptoms
and MDD symptoms to zero was also estimated to evaluate the
importance of the cross-paths for model fit. Comparisons of
the model fits were made using x2 difference tests that were
calculated based on a formula supplied in Satorra (2000) that
accounts for clustered data and incorporates the Satorra–
Bentler scaling corrections provided by Mplus. The AIC is
also reported for these models.
Results
Descriptive statistics, phenotypic correlations, and twin
correlations
Rates of MDD and NicD diagnoses and means and standard
deviations for MDD and NicD symptom counts at each assessment and separately for males and females are presented
in Table 1. As expected, for the combined sample, rates of
both disorders increased considerably with age. The pattern

Table 1. Rates for MDD and NicD at 15, 18, and 21 years by gender and diagnostic status of other disorders and means
(standard deviations) by gender
Diagnoses (%)

NicD
15 Years
18 Years
21 Years
MDD
15 Years
18 Years
21 Years

Dx With/Without Other Dx (%)

Symptom Counts

Male and
Female

Male

Female

Male and
Female

Male

Female

Male and
Female

Male

Female

7.4
23.0
28.1

7.6
28.4
37.0

7.2
17.8
20.2

23.4/6.9
34.8/21.4
38.5/26.7

23.8/7.2
50.0/26.8
52.3/34.9

23.1/6.6
30.0/16.0
28.6/18.8

0.31 (1.08)
0.88 (1.65)
1.13 (1.77)

0.31 (1.05)
1.07 (1.78)
1.53 (1.95)

0.31 (1.10)
0.70 (1.51)
0.78 (1.50)

3.4
7.3
12.3

3.0
3.6
10.6

3.7
10.7
13.9

10.6/2.8
11.3/6.1
16.8/10.5

9.4/2.5
6.5/2.5
15.1/8.0

11.8/3.0
18.3/9.1
19.7/12.4

0.30 (1.13)
0.53 (1.61)
0.81 (2.04)

0.24 (1.05)
0.31 (1.20)
0.71 (1.89)

0.35 (1.21)
0.74 (1.88)
0.90 (2.16)

Note: Rates and symptom counts at 15 years are lifetime until age 15 and at 18 and 21 years are since the previous assessment (approximately the preceding 3
years). MDD, major depressive disorder; NicD, nicotine dependence; Dx, diagnoses. The Dx With/Without Other Dx columns give the rate of the indicated
disorder in youths with the other disorder compared to the rate in those without the other disorder. For instance, 23.4% of depressed 15-year-olds were nicotine
dependent and 6.9% of nondepressed 15-year-olds were nicotine dependent.
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was similar for males and females, except that the largest increase in rates of MDD for females occurred between ages 15
and 18 years and for males occurred between ages 18 and 21
years, which is consistent with later rises in rates of depression for males compared to females (Hankin et al., 1998).
Sex differences in rates of disorders were tested using generalized estimating equations to account for the correlated nature of the twin data. At age 15, there were no significant
sex differences in rates of MDD diagnoses (Wald x2 ¼ 0.42,
p ¼ .52), NicD diagnoses (Wald x2 ¼ 0.12, p ¼ .73), MDD
symptom counts (Wald x2 ¼ 3.39, p ¼ .07), or NicD symptom counts (Wald x2 ¼ 0.00, p ¼ 1.00). Rates of MDD diagnoses (Wald x2 ¼ 21.15, p , .001) and MDD symptom
counts (Wald x2 ¼ 24.44, p , .001) were significantly higher
in females than males at age 18, and rates of NicD diagnoses
(Wald x2 ¼ 21.27, p , .001) and NicD symptom counts (Wald
x2 ¼ 16.77, p , .001) were significantly higher in males than females at age 18. At age 21, diagnoses (Wald x2 ¼ 3.09, p ¼ .08)
and symptom counts (Wald x2 ¼ 2.94, p ¼ .09) for MDD did not
differ significantly by gender, but rates (Wald x2 ¼ 45.24, p ,
.001) and symptom counts (Wald x2 ¼ 60.83, p , .001) for
NicD were significantly higher in males than females.
Phenotypic correlations for MDD and NicD symptoms
counts at all three assessments by gender are presented in
Table 2. Correlations were estimated using weighted least
squares with robust standard errors in Mplus using all available

data and treating twins as clusters. Stability correlations across
time within disorder were positive and significant and were
moderate in magnitude for MDD symptoms and moderate
to high in magnitude for NicD symptoms. Consistent with
comorbidity between these disorders, all contemporaneous correlations between MDD and nicotine were positive and significant, but they were generally small in magnitude and decreased
slightly with age. Correlations between MDD symptoms and
subsequent NicD symptoms and between NicD symptoms
and subsequent MDD symptoms were also positive and significant but small in magnitude. Stability correlations across time
within disorder were generally similar in magnitude for males
and females. Correlations of MDD symptoms with NicD symptoms tended to be slightly higher for females than males.
Table 1 also presents rates of each disorder among individuals with and without the other disorder at each age, which
provides additional information about comorbidity. Rates of
MDD diagnoses were higher among individuals with NicD diagnoses at all three ages for males and females, and rates of
NicD diagnoses were also higher among individuals with
MDD diagnoses at all three ages for males and females. Logistic regression analyses with generalized estimating equations
to account for the nonindependent twin data indicate that individuals with one disorder were more likely to have the other disorder than not to have the disorder at age 15 (Wald x2 ¼ 17.15,
p , .001), age 18 (Wald x2 ¼ 7.82, p ¼ .005), and age 21

Table 2. Phenotypic correlations among MDD and NicD symptoms for combined sample and male
and female samples
NicD
15 Years

18 Years

MDD
21 Years

15 Years

18 Years

21 Years

.24***
.14***

.26***

.13*
.03
.04

.10
.06
.06

.04
.03
.10**

.18*

.07
.28***

Combined Sample
NicD
15 Years
18 Years
21 Years
MDD
15 Years
18 Years
21 Years

.40***
.28***

.56***

.17***
.07
.09**

.08*
.11**
.08*

.07*
.08*
.11**
Male/Female Samples

NicD
15 Years
18 Years
21 Years
MDD
15 Years
18 Years
21 Years

.37***
.49***
.32***

.67***

.20**
.06
.12*

.15**
.18***
.12**

.26***
.54***
.13**
.12*
.12*

.27***
.18***

.25***

Note: Male twins are above the diagonal, and female twins are below the diagonal. MDD, major depressive disorder; NicD, nicotine
dependence.
*p , .05. **p , .01. ***p , .001.

Changes in genetic and environmental influences on NicD and MDD

(Wald x2 ¼ 9.23, p ¼ .002). This evidence of comorbidity was
found for males at each age (Wald x2 s . 4.63, ps . .03) and
females at each age (Wald x2 s . 4.80, ps . .03).
Twin intraclass within-trait correlations by zygosity and
gender are presented in Table 3. These correlations provide
information about genetic and environmental influences on
NicD and MDD symptoms at each age. The correlations for
NicD symptoms were significant, approximately equal, and
moderately large for MZ and DZ twins at age 15, indicating
little to no genetic effects but some shared environmental effects. This was true for male and female twin pairs. At age 18,
the magnitude of the correlations for NicD symptoms was
significant for both MZ and DZ twin pairs, but the magnitude
of the correlation was nearly twice as large for MZ twin pairs
as for DZ twin pairs. From age 15 to 18, the MZ twin correlations increased slightly and the DZ correlations decreased
slightly. Overall, these correlations indicate increasing genetic influences and decreasing shared environmental influences on NicD symptoms during late adolescence. At age
21, the MZ NicD symptom correlations remained relatively
stable while the DZ correlations continued to decrease, suggesting continued declines in shared environmental influences. These patterns are generally similar for male and female twin pairs, with the exception that at age 21, the DZ
correlation was not significant and small in magnitude for
males but remained significant and moderate in magnitude
for females. Altogether, these correlations provide preliminary evidence of age-related increases in heritability.
Overall, the intraclass correlations are smaller for MDD
symptoms than for the NicD symptoms, which suggest smaller
genetic and shared environmental influences and larger nonshared environmental influences on MDD symptoms than
NicD symptoms. For MDD at age 15, the MZ correlation is
nonsignificant while the DZ correlation is significant. This unexpected pattern of correlations is present only among females,
and may stem from the fact that depression is not common at
this age, thus reducing our ability to reliably estimate twin
similarity at this age. At ages 18 and 21, the MZ correlations
were higher than the DZ correlation. This pattern is true for
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both male and female twin pairs, although the pattern is somewhat more pronounced for males than females. The MZ correlations were relatively stable between age 18 and 21, while the
DZ correlations decreased slightly from age 18 to age 21.
Overall, these correlations suggest that both the genetic and
shared environmental influences on MDD will be small, but
the genetic influences will increase slightly with age.
Biometric model fitting
NicD symptoms. Findings from the Cholesky model for NicD
symptoms (Figure 2) were consistent with the twin correlations in that heritability and nonshared environmental influences tended to increase with age. The unstandardized variance estimates (presented in the table in the lower left
portion of the figure) indicate that as expected the total variance in NicD increased with age as did genetic variance
(which increased considerably between ages 15 and 18 and
only slightly between ages 18 and 21) and nonshared environmental variance. By contrast, the shared environmental variance is small at all three ages and decreased slightly with
age. Table 4 displays test statistics for comparisons of model
fits. Worsening of model fit between the fully age-constrained model (Model 1) and age unconstrained model
(Model 2) indicate that A, C, and E could not be constrained
to be equal across all ages without significantly reducing the
fit of the model. A more specific nested model with A constrained to be equal across the three ages also worsened the
fit of the model (Model 3), suggesting that estimates of genetic influence could not be constrained to be equal across
ages. Because additive genetic estimates were similar at ages
18 and 21, a model with A constrained to be equal at ages 18
and 21 but free to vary between age 15 and the two older ages
(model 4) was also compared to the age unconstrained model.
This model provided a better fit to the data and the AIC indicates that this model is preferred to the model with A constrained across all three ages. The small shared environmental
influences could be constrained to be equal across all three
ages (Model 5). The nonshared environmental influences,

Table 3. Twin intraclass correlations for NicD and MDD symptoms by zygosity and age
Male

NicD
15 Years
18 Years
21 Years
MDD
15 Years
18 Years
21 Years

Female

MZ

DZ

MZ

DZ

.51***
.60***
.55***

.49***
.37***
.21**

.53***
.58***
.51***

.45***
.36***
.11

.02
.28***
.28***

.23***
.20**
.14*

.12*
.35***
.28***

.13
.12
.06

MZ
.48***
.60***
.62***
2.08
.24***
.25***

DZ
.51***
.38***
.32***
.28**
.22**
.15*

Note: Male twins are above the diagonal, and female twins are below the diagonal. NicD, nicotine dependence; MDD,
major depressive disorder; MZ, monozygotic; DZ, dizygotic.
*p , .05. **p , .01. ***p , .001.
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Figure 2. A standardized path diagram of the full Cholesky decomposition model for nicotine dependence symptoms (NicD Sx) with 95% confidence intervals (CI) for the parameters shown in the model. Path coefficient estimates have been squared and represent the proportion of variance in NicD accounted for by the components. The tables at the bottom of the figure include (a) the overall proportions of variance in NicD
attributed to (and the unstandardized variance estimates for) genetic, shared environmental, and nonshared environmental influences at each age
and (b) the standardized and squared shared environmental path coefficients. Ai , variance attributable to additive genetic effects; Ei , variance
attributable to nonshared environmental effects; a 2 , c 2 , and e 2 , squared path coefficients for genetic, shared environmental, and nonshared environmental influences, respectively.

which increased with age, could not be constrained to be equal
across the three ages (Model 6). Thus, the best-fitting model
(Model 7) is one in which genetic influences are free to vary
between age 15 and ages 18 and 21 but constrained to be equal
at ages 18 and 21, shared environmental influences are constrained to be equal across all ages, and nonshared environmental influences are free to vary at each age. With the exception of the small and relatively stable shared environmental
variance, these findings were consistent with expectation
and aid the interpretation of the standardized estimates that
are also presented in Figure 2.
Standardized estimates, which provide a comparison of
relative proportions of variance in NicD symptoms attributed
each of the three sources of variance, are also shown in Figure 2. These standardized variance estimates also indicate that
the proportions of variance in NicD symptoms accounted for
by genetic influences increased between age 15 and 18 and
were relatively stable between ages 18 and 21. The proportion
of variance accounted for by shared environmental influences
decreased from age 15 to 18 and from age 18 to 21, decreasing by about 80% between ages 15 and 21. Although the

magnitude of shared environmental influences was larger
than the magnitude of genetic influences at age 15, the reverse
was true at ages 18 and 21 when the shared environmental estimates were small and nonsignificant. The proportions of the
variance attributed to nonshared environmental influences
were relatively stable with the largest proportion at age 21.
Despite changes in the relative magnitude of genetic effects
across ages, there was considerable overlap in genetic influences across ages. Almost half of the genetic influences on
NicD symptoms present at age 18 were present at age 15,
and 81% of the genetic influences present at age 21 were present at an earlier age (20% at age 15, 61% at age 18). Nonshared environmental influences were almost entirely age
specific. Only 3% nonshared environmental effects at age
18 were present at age 15, and 6% of the nonshared environmental effects at age 21 were present at age 18 (0% at age 15).
In summary, genetic contributions to the variance in NicD
symptoms increased with age while the proportion of variance attributed to shared environmental contributions decreased with age, and the proportion of variance attributed
to nonshared environmental contributions remained relatively
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Table 4. Test statistics for Cholesky decomposition model
for nicotine dependence symptoms with constraints
across ages
Model
1. Ageunconstrained
model
2. Fully age
constrained
3. Constrain A
across age
4. Constrain:
A: ages 18 and
21 years
5. Constrain C
across age
6. Constrain E
across age
7. Constrain:
A: ages 18
and 21 years
C: all ages

22LL

df

D22LL (df )

281.54

66

780.43

72

498.98 (6)

,.001

636.43

303.73
281.94

68
67

22.19 (2)
0.38 (1)

,.001
.54

167.73
145.94

282.12

68

0.58 (2)

.75

146.12

471.46
282.16

68
69

189.92 (2)
0.62 (3)

,.001
.89

335.46
144.16

p

AIC

149.54

Note: Separate variance–covariance matrices were used for males and females. The unconstrained model is unconstrained across ages but is constrained across sexes. 22LL, 22 times the log likelihood; D22LL, differences in 22LL values between the sex-constrained but age-unconstrained
model (Model 1); AIC, Akaike information criteria; A, additive genetic effects; C, shared environmental effects; E, nonshared environmental effects.
The best fitting model is in bold.

stable across the three ages. Some genetic influences were present at all ages, which contributed to the stability of NicD
symptoms between ages 15 and 21. Although nonshared environmental influences were significant and moderate in magnitude at each age, these nonshared influences contributed little
to the stability in NicD symptoms across the three ages but
instead reflected age-specific (i.e., new or unique) environmental influences that were not present at earlier ages.
MDD symptoms. Estimates from the Cholesky model for
MDD symptoms were also consistent with the twin correlations
(Figure 3) in that heritability effects became stronger with age.
As was expected and was the case for NicD, total variance in
MDD increased with age, as did genetic variance (which increased more between ages 15 and 18 than between ages 18
and 21) and nonshared environmental variance. Shared environmental variance was generally small and remained stable
between ages 15 and 18 and then decreased slightly between
ages 18 and 21. Test statistics for models of MDD symptoms
are presented in Table 5. Comparison of the age unconstrained
(Model 1) and fully age-constrained (Model 2) models indicated significant heterogeneity in the parameter estimates
across the ages. Constraining A across all three ages (Model
3) worsened the fit of the model. The more specific model constraining A at ages 18 and 21 while allowing A to vary at age 15
(Model 4) improved the fit of the model. Constraining C across
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all three ages (Model 5) also improved the fit of the model,
while constraining E across ages (Model 6) worsened the fit
of the model. As follows, consistent with most predictions (except the prediction of decreasing shared environmental influences), in the best-fitting model (Model 7), genetic influences
were constrained to be equal at ages 18 and 21 and free to vary
at age 15, shared environmental influences were constrained to
be equal at all three ages, and nonshared environmental influences were free to vary across all three ages. Thus, the same
model fit best for MDD symptoms and NicD symptoms.
The standardized estimates in Figure 3 indicate that almost
all variance in MDD symptoms at age 15 can be attributed to
nonshared environmental effects, but again it is important to interpret these findings with caution given the low variability in
symptom counts and unexpected higher twin correlations for
DZ than MZ twins. The proportion of variance attributed to genetic influences increased between age 15 and 18 and then for
the most part leveled off between ages 18 and 21. Shared environmental contributions were generally small at each age but
decreased from age 15 to 18 and from age 18 to 21. The proportion of variance attributed to nonshared environmental influences continued to predominate at all ages. Most of the genetic
effect at ages 18 and 21 was present at the previous ages, indicating few age-specific or new genetic influences with age. Notably, approximately 80% of the genetic influence at age 18 was
present at age 15, and 100% of the genetic influence at age 21
was present at an earlier age. Nonshared environmental influences were almost entirely age specific and therefore did not
contribute to the stability of MDD symptoms across ages.
Shared environmental effects were small and contributed little
to the stability of MDD.
Overall, the Cholesky model of MDD symptoms indicated
increasing genetic contributions, small and decreasing shared
environmental contributions, and very large nonshared environmental influences across the three ages. Most of the genetic influences were common to all three ages, with little
evidence of age-specificity of these influences. Nonshared
environmental influences were virtually entirely age-specific.
Thus, similar to the findings for NicD symptoms, stability of
symptoms was explained largely by genetic influences.
Cross-lagged model fitting
As previously presented, NicD symptoms and MDD symptoms were stable within disorders across time and were correlated with one another concurrently and across ages (see
Table 2). Figure 4 displays the cross-lagged model with parameters constrained to be equal across sexes with mean levels
of symptoms free to vary between the sexes, which results
in different standardized estimates for males and females.
Stability correlations within disorders between ages 15 and
18 and between 18 and 21 were significant and stronger for
NicD symptoms than MDD symptoms. This indicates that
each disorder predicted increased risk for the same problem
over time. Parameters for all cross-lag paths connecting one
disorder at an earlier time point to the other disorder at a later
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Figure 3. A standardized path diagram of the full Cholesky decomposition model for major depressive disorder symptoms (MDD Sx) with 95%
confidence intervals for the parameters shown in the model. Path coefficient estimates have been squared and represent the proportion of variance
in MDD accounted for by the components. The tables at the bottom of the figure include (a) the overall proportions of variance in MDD attributed
to (and the unstandardized variance estimates for) genetic, shared environmental, and nonshared environmental influences at each age and (b) the
standardized and squared shared environmental path coefficients. Ai , variance attributable to additive genetic effects; Ei , variance attributable to
nonshared environmental effects; a 2 , c 2 , e 2 , squared path coefficients for genetic, shared environmental, and nonshared environmental influences, respectively.

time point were small in magnitude and nonsignificant. A x2
difference test revealed a nonsignificant decrease in the fit for
the model with all cross-paths between the two disorders
fixed to zero: Dx 2 (4) ¼ 4.36, p ¼ .36. MDD symptoms at
an earlier point in time did not predict NicD symptoms at a
later point in time, and NicD symptoms at an earlier point
in time did not predict MDD symptoms at a later point in
time. Correlations between the innovations were small in
magnitude and significant at age 18 but nonsignificant at
age 21. In other words, there is a small but significant association between new sources of variance in NicD symptoms
at age 18 and new sources of variance in MDD symptom at
age 18 that are not accounted for by either disorder at age 15.1
1. The longitudinal relationships between categorically diagnosed MDD and
NicD were also examined using a similar cross-lagged model, again accounting for the twin data by nesting twins within twin pairs. Findings
from this diagnosis-based model were similar to those reported for the
symptom count model. No cross-paths between MDD and NicD diagnoses across any ages were significant, and there was a nonsignificant decrease in the fit of the model when all cross-paths between the two were
constrained to zero, Dx 2 (3) ¼ 3.40, p ¼ .33.

Discussion
The purpose of this study was to use longitudinal models to
examine developmental shifts in the genetic and environmental influences underlying the emergence of NicD symptoms and MDD symptoms across the high-risk period of middle adolescence, when depressed mood and smoking initiation
are emerging, to early adulthood, when point prevalence rates
of both disorders have reached their peaks, and to examine
the longitudinal associations between NicD and MDD symptoms after accounting for developmental continuity of these
phenotypes. The findings support active, dynamic processes
involving developmental changes in the magnitude of genetic
and environmental influences on both NicD and MDD symptoms but no evidence supporting longitudinally predictive
relationships between MDD and NicD symptoms after accounting for the stability and concurrent associations of these
disorders.
As hypothesized, genetic influences on NicD and MDD
symptoms increased between age 15 and age 18, a developmental period when independence and niche fitting are likely
to accelerate, but were relatively stable between ages 18 and
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Table 5. Test statistics for Cholesky decomposition model
for major depressive disorder symptoms with constraints
across ages
Model
1. Ageunconstrained
model
2. Fully age
constrained
3. Constrain A
across age
4. Constrain:
A: ages 18
and 21 years
5. Constrain C
across age
6. Constrain E
across age
7. Constrain:
A: ages 18
and 21 years
C: all ages

22LL

df

370.61

66

684.42

72

384.93
371.58

D22lnL (df )

p

AIC

,.001

238.61

313.81 (6)

,.001

540.42

68
67

14.32 (2)
0.97 (1)

,.001
.32

248.93
237.58

370.64

68

0.03 (2)

.99

234.64

451.71
373.15

68
69

81.10 (2)
2.54 (3)

,.001
.47

315.71
235.15

Note: Separate variance–covariance matrices were used for males and females. The unconstrained model is unconstrained across ages but is constrained across sexes. 22LL, 22 times the log likelihood; D22LL, differences in 22LL values between the sex-constrained but age-unconstrained
model (Model 1); AIC, Akaike information criteria; A, additive genetic effects; C, shared environmental effects; E, nonshared environmental effects.
The best fitting model is in bold.

21. The rise in the influence of genetic factors demonstrated
in this study likely occurred within the context of a cascade of
interacting genes and environmental exposures that unfold
over time and begin to emerge as symptoms of NicD and
MDD during middle adolescence. Consistent with this idea,
the present study findings also support the importance of
environmental influences on MDD and NicD during this period, particularly environmental factors unique to individuals
rather than shared among family members. The increase in
variance attributed to nonshared environmental influences
may reflect key developmental tasks occurring during adolescence, such as growing independence, greater involvement
with peers, and more time spent in extracurricular activities
away from the family. Depression and nicotine use during adolescence have been associated with many such social risk factors, for example, affiliation with peers who smoke and engage
in deviant behavior (Hu et al., 2006), peer rejection and victimization (Prinstein, Cheah, & Guyer, 2005), and peer relationships characterized by conflict and lack of trust (Eberhart &
Hammen, 2006). These cascades of interacting genetic and
environmental influences on NicD and MDD occur within
the context of other developmentally relevant domains of functioning (e.g., academic achievements, career successes and failures, interpersonal relationship problems), which may also influence the developmental course of NicD and MDD. Future
research may investigate these moderating influences, for in-
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stance, by testing hypotheses about larger genetic effects or
stronger age-related increases in genetic influences for individuals who have high levels of affiliation with deviant peers,
have experienced romantic relationship breakups, or fail to
complete schooling and/or obtain employment.
For both NicD and MDD, genetic influences on symptoms
overlapped considerably across the three ages, suggesting that
genetic factors are a significant part of the processes underlying the continuity of symptoms across development. In contrast, nonshared environmental factors were almost entirely age
specific and thus contributed little to the stability of NicD and
MDD symptoms across time. Instead, different nonshared environmental factors influenced MDD and NicD symptoms at different points in development. Changes in environmental risk
factors are consistent with the major developmental transitions
that occur during this period. For example, conflict with parents
is an important predictor of psychopathology and substance use
during adolescence (McGue, Elkins, Walden, & Iacono, 2005)
but is not likely to be as influental after young adults have
moved out of their parents’ homes.
The small shared environmental variance for both MDD
and NicD across all three ages was somewhat surprising, and
may help explain inconsistencies in estimates of shared environmental influences across previous twin studies. Consistent
with our summary of existing twin research on depression and
smoking in samples of youths, at younger ages shared environmental influences accounted for a larger proportion of variance
in symptoms than genetic influences for both phenotypes (but
especially for NicD), and at older ages the reverse was true for
both disorders. The proportions of variability accounted for by
shared environmental influences diminished with age to nearly
zero by early adulthood. It is important to note, though, that
the decline in the relative proportion of shared environmental
influence compared to genetic and nonshared environmental
influences is almost entirely a reflection of the rather dramatic
increase in both genetic and nonshared environmental variance
during this period, rather than the slight (and nonsignificant)
decline in shared environmental variance.
Because symptoms of NicD were more heritable than
symptoms of MDD and environmental factors shared among
family members (although minimally influential overall) were
more important for NicD than MDD, it follows that environmental influences unique to each twin were more important
sources of variability in MDD symptoms than NicD symptoms. Actually, 66% to 88% of the variability in MDD symptoms could be attributed to these influences. Characteristics
of the family environment, such as family stress (Fendrich,
Warner, & Weissman, 1990), parent–child conflict (Shiner
& Marmorstein, 1998), and interparental conflict (Fergusson,
Horwood, & Lynskey, 1995) have consistently been found
to be important correlates of elevated risk for depression in
adolescents. Integrating this research with our findings suggests that the role of these family factors in the development
of depression is via individual processes not shared among
family members (i.e., diverse experiences and responses to
family stress and conflict for different family members), an
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Figure 4. A cross-lag model with parameters constrained to be equal across sexes, mean levels of symptoms free to vary between the sexes,
and different standardized estimates for males and females. Standardized parameter estimates (with standard errors) are displayed and can be
interpreted in standard deviation units. Parameters for males are displayed above the parameters for females. The letter “I” denotes innovations, and curved arrows connecting two innovations represent correlations between the innovations. The values next to the curved arrows represent Pearson correlations. NicD Sx, nicotine dependence symptoms; MDD Sx, major depressive disorder symptoms. *p , .05. **p , .01.
***p , .001.

idea consistent with developmental psychopathology principles that emphasize individual trajectories of risk (Rutter &
Sroufe, 2000) and the tendency for individuals to experience
and perceive family characteristics in different ways (Rutter,
1999).
Finally, as expected, there was considerable developmental
continuity of MDD and NicD symptoms across adolescence
and into early adulthood. Within disorder stability was stronger
for NicD than MDD, which may be related to the episodic
nature of depression and to stronger genetic influences on
NicD symptoms than MDD symptoms, because genetic effects were shown to contribute to stability of symptoms over
time. Consistent with research supporting the co-occurrence
of smoking and depressed mood in adolescents and young
adults (Fergusson et al., 1996), NicD symptoms were associated concurrently with MDD symptoms at all three ages, and
diagnoses of MDD were more common among individuals
with NicD and vice versa. These associations were relatively
small in magnitude, which is not unexpected given variability
in effect sizes for associations between smoking and depression in the literature and the paucity of comparable research
employing interviews to measure clinically relevant constructs in adolescents and young adults. Although we identified small, significant associations between symptoms of
the disorders across ages, after accounting for stability within

disorders over time, associations between symptoms of one
disorder at an earlier point in time did not predict symptoms
of the other disorder at a later point in time. The cross-lagged
model, though, supported correlated age-specific sources of
variance for NicD and MDD symptoms at age 18, indicating
that the two disorders have correlated risk factors and perhaps share common nonshared environmental risk factors,
possibly risks related to peer affiliation and relationships.
Because most previous studies did not adequately account
for stability within disorders across time or use clinically relevant measures, these findings provide important new information about the longitudinal relationships between MDD
and NicD.
Strengths and Limitations
A few study limitations should be noted. First, the measures
of depression and nicotine use selected for this study had clinical relevance but were limited in their developmental sensitivity to the emergence of problems and ability to detect
variability in symptoms at age 15, perhaps contributing to
the small magnitude MZ twin correlations evident at age
15. Use of more developmentally sensitive measures (e.g., initiation of smoking, less severe depressed mood) may provide
more variability, reliability of estimates, and the ability to ex-
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amine genetic and environmental effects at younger ages.
However, our study had the advantage of assessing the
same clinically relevant measures of DSM criteria across all
three assessments, and the low rates of symptom endorsement
at age 15 are descriptive of individuals at this age in this general population sample.
Second, although an important strength of the clinical interviews was their ability to assess symptoms during the entire period between time points, the 3-year intervals may
have been too long to detect the predictive effects of one of
these disorders on the other. For instance, MDD may predict
NicD when NicD is measured immediately following a depressive episode, with this effect weakening over longer durations of time. Future research that studies the longitudinal relationship between these constructs across the same high-risk
developmental period but at shorter intervals may pinpoint a
more precise timeline (especially between ages 15 and 18)
when the developmental shifts in genetic and environmental
effects occur.
Third, biometric modeling partitions variance into additive genetic, shared environmental, and nonshared environmental effects but does not provide information about specific genes, environmental risks, or targets for interventions
and does not inform about causal processes (Rutter & Sroufe,
2000). The Cholesky decomposition models used in this
study do not separate or identify gene–environment or epistatic genetic effects. Research on the interplay of specific
genes and environmental risk factors across this developmental period will be important for specifying the nature of
changing etiological factors.
Fourth, the participants were primarily Caucasian, which
reflects the community from which the twins were selected
but limits generalizability of the findings to other groups. In
addition, because the participants in the study were twins,
the findings may not be applicable to singletons. However,
various lines of research support the applicability of findings
from samples of twins, such as studies finding few differences
in rates of psychopathology between twins and singletons
(e.g., Kendler, Martin, Heath, & Eaves, 1995).
This study also has several methodological strengths.
First, the age range of participants was broad (15–21 years),
but participants were assessed at discrete ages (i.e., variability
in age at each assessment was low), which provided the opportunity to study change across the high-risk period while
also examining effects at important, distinct points during
development. Second, the sample had low attrition across
assessments and was a representative community sample,
which makes it possible to generalize findings to nonclinical
populations. Third, clinical interviews were used to assess
symptoms throughout the entire period from age 15 to 21,
which provides clinically relevant measures and fills gaps
in behavior genetics research on depression and nicotine
use in youth samples, which have almost exclusively relied
on self-report measures of current problems. These strengths,
especially the longitudinal design, clinical measures, discrete
ages at assessments, and models that account for limitations
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in the previous research (e.g., stability of disorders), allowed
us to address unanswered questions about age-related changes
in the genetic and environmental influences on MDD and
NicD and longitudinal associations between MDD and NicD
during the critical years of adolescence and early adulthood.
Conclusion
In summary, genetic and environmental factors were involved
in the developmental cascade of risks explaining the rise in
symptoms of NicD and MDD between age 15, when levels
of symptoms were low and individual variability in symptoms were small, and late adolescence/early adulthood,
when symptoms were at peak levels and individual variability
was more substantial. This high risk period, especially between ages 15 and 18 years, is a critical time for changes in
etiological factors as genetic influences become more important, new genetic influences emerge, and nonshared environmental influences contribute to greater variability in susceptibility to MDD and NicD. Individuals high in symptoms of one
disorder were likely to be high in symptoms of the same disorder later in development. This developmental continuity
was largely explained by genetic factors. Environmental factors uniquely experienced by one twin and not the other
were influential in the development of both disorders, but especially depression. These environmental factors were developmentally specific and tended to explain variability at only
one age. MDD and NicD symptoms co-occurred at the same
time, had small associations across ages, and had correlated
age-specific risk factors at age 18. However, after accounting
for the stability of the two disorders, there were not cumulative
cascade effects from one disorder to the other over the assessed
time intervals, calling into question the causal role of one disorder in the cascade preceding the development of the other
disorder.
Understanding developmental changes in genetic and
environmental factors has implications for intervening and
treating NicD and MDD. Given the large overlap in genetic
influences across the three discrete ages, early interventions
that target children with high genetic risk (e.g., a parent with
the disorder) may yield “high returns” (Heckman, 2006) and
thus may help reduce the economic and health burdens associated with these disorders. Furthermore, identifying intergenerational cascades of effects that link risk in one generation
with risk in the next generation has practical implications for
pinpointing and targeting specific predictors of risk and “buffers” that promote resilience (Serbin & Karp, 2004). For example, interventions for children of depressed parents may
target building resilience to genetic risks, such as developing
skills to minimize the effects of their own genetically influenced proneness to negative affectivity, and protecting
against environmental mechanisms of intergenerational transmission of risk, such as learning to cope with the fluctuating
moods and parenting practices of their depressed parent. The
development of effective resilience skills may ultimately reduce negative chain reactions (Rutter, 1999) and help prevent
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problems across development. At the same time, given evidence of age-specific genetic and environmental risk factors,
preventative interventions must be ongoing, take into account
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individual family members’ unique experiences of family
risk factors, adjust to individuals’ developmental levels, and
consider age-specific risk factors.
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